DIVYA GUPTA, MD
Hematology & Oncology Physician · CHICAGO, IL
Individual Active NPI 1366975583
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 212 | 58,213 | $5,684,293 | $1,496,902 | $1,191,390 |
| 2023 | 74 | 17,292 | $867,986 | $221,206 | $176,296 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1453 | Injection, fosaprepitant, 1 mg | 6,900 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 5,800 | $56 | $45 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 4,580 | $3 | $2 |
| J1756 | Injection, iron sucrose, 1 mg | 3,700 | $0 | $0 |
| J9305 | Injection, pemetrexed, not otherwise specified, 10 mg | 2,510 | $4 | $4 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 508 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 460 | $1 | $1 |
| J9045 | Injection, carboplatin, 50 mg | 306 | $4 | $3 |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 228 | $66 | $52 |
| 99215 | Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 210 | $187 | $149 |
| Q5111 | Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 168 | $160 | $128 |
| 96375 | Injection of additional new drug or substance into vein | 138 | $16 | $12 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 036165555 | IL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Illinois
- NPI 1871239582
- NPI 1629603139
- NPI 1033798905
- NPI 1285995266
- NPI 1407899198
- NPI 1467846360
- NPI 1881156289
- NPI 1831295211
See all Hematology & Oncology Physician providers in Illinois →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.